Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Aghaei Bandbon Balenga Nariman |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2014
Originalarbeit (Zeitschrift)
** Balenga, NA; Martínez-Pinilla, E; Kargl, J; Schröder, R; Peinhaupt, M; Platzer, W; Bálint, Z; Zamarbide, M; Dopeso-Reyes, IG; Ricobaraza, A; Pérez-Ortiz, JM; Kostenis, E; Waldhoer, M; Heinemann, A; Franco, R
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
Br J Pharmacol. 2014; 171(23):5387-5406
Doi: 10.1111/bph.12850
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Originalarbeit (Zeitschrift)
** Kargl, J; Balenga, N; Parzmair, GP; Brown, AJ; Heinemann, A; Waldhoer, M
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
J Biol Chem. 2012; 287(53):44234-44248
Doi: 10.1074/jbc.M112.364109
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kargl, J; Balenga, NA; Platzer, W; Martini, L; Whistler, JL; Waldhoer, M
The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
Br J Pharmacol. 2012; 165(8):2611-2619
Doi: 10.1111/j.1476-5381.2011.01562.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Balenga, NA; Aflaki, E; Kargl, J; Platzer, W; Schröder, R; Blättermann, S; Kostenis, E; Brown, AJ; Heinemann, A; Waldhoer, M
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.
Cell Res. 2011; 21(10):1452-1469
Doi: 10.1038/cr.2011.60
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Übersichtsarbeit
** Henstridge, CM; Balenga, NA; Kargl, J; Andradas, C; Brown, AJ; Irving, A; Sanchez, C; Waldhoer, M
Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.
Mol Endocrinol. 2011; 25(11): 1835-1848.
Doi: 10.1210/me.2011-1197
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Originalarbeit (Zeitschrift)
** Henstridge, CM; Balenga, NAB; Schroder, R; Kargl, JK; Platzer, W; Martini, L; Arthur, S; Penman, J; Whistler, JL; Kostenis, E; Waldhoer, M; Irving, AJ
GPR55 ligands promote receptor coupling to multiple signalling pathways.
BRIT J PHARMACOL. 2010; 160(3): 604-614.
Doi: 10.1111/j.1476-5381.2009.00625.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2009
Originalarbeit (Zeitschrift)
** Henstridge, CM; Balenga, NA; Ford, LA; Ross, RA; Waldhoer, M; Irving, AJ
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
FASEB J. 2009; 23(1): 183-193.
Doi: 10.1096/fj.08-108670
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2008
Originalarbeit (Zeitschrift)
** Waldeck-Weiermair, M; Zoratti, C; Osibow, K; Balenga, N; Goessnitzer, E; Waldhoer, M; Malli, R; Graier, WF
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression.
J Cell Sci. 2008; 121(Pt 10): 1704-1717.
Doi: 10.1242/jcs.020958
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2007
Kurzbericht/Letter
** Balenga, NA; Balenga, NA
Human TLR11 gene is repressed due to its probable interaction with profilin expressed in human.
Med Hypotheses. 2007; 68(2): 456-456.
Doi: 10.1016/j.mehy.2006.07.015
Web of Science
PubMed
FullText
FullText_MUG
** Balenga, NA; Rafati, S
Innate immune system: specific or non-specific?
Med Hypotheses. 2007; 69(2):460-461
Doi: 10.1016/j.mehy.2007.01.003
Web of Science
PubMed
FullText
FullText_MUG
2006
Originalarbeit (Zeitschrift)
** Balenga, NA; Zahedifard, F; Weiss, R; Sarbolouki, MN; Thalhamer, J; Rafati, S
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy.
J Biotechnol. 2006; 124(3): 602-614.
Doi: 10.1016/j.jbiotec.2006.01.014
Web of Science
PubMed
FullText
FullText_MUG
** Bandbon Balenga, NA; Thalhamer, J; Weiss, R
Bicistronic expression plasmid encoding allergen and anti-IgE single chain variable fragment antibody as a novel DNA vaccine for allergy therapy and prevention.
Med Hypotheses. 2006; 67(1): 71-74.
Doi: 10.1016/j.mehy.2005.12.044
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Balenga, NA
Controlled release of DNA vaccines: does in vitro release profile correlate with immune response?
Med Hypotheses. 2006; 66(4): 864-865.
Doi: 10.1016/j.mehy.2005.11.031
Web of Science
PubMed
FullText
FullText_MUG